MAS' divestiture of Kichler Lighting focuses on core strengths, boosting the stock's potential.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Masco's (MAS) second-quarter 2024 results benefit from operational improvements.
While the top- and bottom-line numbers for Masco (MAS) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Masco (MAS) came out with quarterly earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.19 per share a year ago.
Masco's (MAS) second-quarter results are likely to reflect inflationary pressure and demand softness.
French investment firm Ardian has bought a majority stake in Italian pharmaceutical and biotech company Masco, the firms said on Monday, in a deal which two sources said gave an enterprise value of around 700 million euros ($762 million) for the stake.
Masco Corporation stock has performed well since my previous bullish article, gaining over 30%. Expectations for revenue recovery are low going into Q2 earnings, but stabilizing demand trends are expected. The company is gaining market share, benefiting from strength in PRO paints channel and secular demand trends in repair and remodeling sectors.
Shares of Masco Corporation have largely followed the market higher since I last rated the firm a 'hold' in October 2022. This is in spite of a decline in revenue and due in part to a rise in profits and cash flows. The picture for the business is improving, but it's not ready for an upgrade, even as earnings near.
Masco (MAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.